Our data of Floridian patients collected at two large academic centers showed two stand out differences on NGS; IDH1 mutations were underrepresented, and WT1 mutations were enriched in Hispanic patients compared to non‐Hispanics, with a possibly lower overall mutational burden in Hispanic AML patients (possibly explained by younger age at presentation). This evidence concerns the gene IDH1 and acute myeloid leukemia.